MedPath

Effectiveness of a titratable mandibular advancement splint for the treatment of obstructive sleep apnoea

Completed
Conditions
Obstructive Sleep Apnoea
Respiratory - Sleep apnoea
Registration Number
ACTRN12606000464561
Lead Sponsor
Dr Alister Neill, Primary investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

Apnoea hypopnoea index 10-40/hour on diagnostic sleep study, two symptoms of obstructive sleep apnoea, body mass index < 32kg/m2, minimum of 8 teeth, ability to protude the mandible by at least 6mm.

Exclusion Criteria

Exaggerated gag reflex, tempero-mandibular joint disease, presence of additional sleep disorder, significant co-morbidity.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Apnoea hypopnoea index[Baseline, 3 weeks (active group), 6 weeks (active and control group).]
Secondary Outcome Measures
NameTimeMethod
Compliance with treatment [3 and 6 weeks];Side effects [3 and 6 weeks]
© Copyright 2025. All Rights Reserved by MedPath